triple-negative-breast-cancer

Documents about triple-negative-breast-cancer

• 68Ga-FAPI-46 PET/CT for Predicting Histological Response in Triple-negative Breast Cancer (FAP-IT)#18622ClinicalTrials.gov
• VISION: Triple Negative Breast Cancer Sample and Clinical Data Acquisition Study#67874ClinicalTrials.gov
• ARGONAUT: Stool and Blood Sample Bank for Cancer Patients#121332ClinicalTrials.gov
• A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors#123471ClinicalTrials.gov
• Safety and Immunogenicity of a Personalized Synthetic Long Peptide Breast Cancer Vaccine Strategy in Patients With Persistent Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy#123570ClinicalTrials.gov
• Reverse Triple Negative Immune Resistant Breast Cancer#325309ClinicalTrials.gov
• A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.#349949ClinicalTrials.gov
• A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer#353297ClinicalTrials.gov
• An immunological signature to predict outcome in patients with triple-negative breast cancer with residual disease after neoadjuvant chemotherapy#26106HAL (France)

Related topics